Allogeneic marrow transplantation in children with acute leukemia: Careful comparison with chemotherapy alternatives required

Leukemia

Volumn 24, Issue 6, 2010, Pages 1212-1216

  Pulsipher, M A ^a   Hunger, S P ^b   Gamis, A S ^c   Wall, D A ^d   Grupp, S A ^e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c CHILDREN S MERCY HOSPITAL   (United States)

^d CancerCare Manitoba ^*  (Canada)

^e CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; LEUKOCYTE ANTIGEN; VINCRISTINE; ANTINEOPLASTIC AGENT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ACUTE MYELOBLASTIC LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER RISK; CANCER SURVIVAL; CHILDHOOD LEUKEMIA; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; LETTER; OVERALL SURVIVAL; PRIORITY JOURNAL; WHOLE BODY RADIATION; ACUTE DISEASE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIAL; COMPARATIVE STUDY; LEUKEMIA; MULTIMODALITY CANCER THERAPY; NOTE; REMISSION; TREATMENT OUTCOME;

ACUTE DISEASE; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; CHILD; CLINICAL TRIALS AS TOPIC; COMBINED MODALITY THERAPY; HUMANS; LEUKEMIA; REMISSION INDUCTION; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77954579164     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2010.72     Document Type: Letter

References (9)

1. Pinkel D. 'Allogeneic marrow transplantation in children with acute leukemia: a practice whose time has gone': twenty years later. Leukemia 2009; 23: 2189-2196.
2. MacMillan ML, Davies SM, Nelson GO, Chitphakdithai P, Confer DL, King RJ et al. Twenty years of unrelated donor bone marrow transplantation for pediatric acute leukemia facilitated by the National Marrow Donor Program. Biol Blood Marrow Transplant 2008; 14 (9 Suppl): 16-22.
3. Schultz KR, Bowman WP, Aledo A, Slayton WB, Sather H, Devidas M et al. Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a Children's Oncology Group study. J Clin Oncol 2009; 27: 5175-5181.
4. Goldsby RE, Liu Q, Nathan PC, Bowers DC, Yeaton-Massey A, Raber SH et al. Late-occurring neurologic sequelae in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study. J Clin Oncol 2010; 28: 324-331.
5. Eapen M, Rubinstein P, Zhang MJ, Stevens C, Kurtzberg J, Scaradavou A et al. Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukaemia: a comparison study. Lancet 2007; 369: 1947-1954. (Pubitemid 46874578)
6. Lawson SE, Harrison G, Richards S, Oakhill A, Stevens R, Eden OB et al. The UK experience in treating relapsed childhood acute lymphoblastic leukaemia: a report on the medical research council UKALLR1 study. Br J Haematol 2000; 108: 531-543. (Pubitemid 30196250)
7. Malempati S, Gaynon PS, Sather H, La MK, Stork LC. Outcome after relapse among children with standard-risk acute lymphoblastic leukemia: Children's Oncology Group study CCG-1952. J Clin Oncol 2007; 25: 5800-5807.
8. Eapen M, Raetz E, Zhang MJ, Muehlenbein C, Devidas M, Abshire T et al. Outcomes after HLA-matched sibling transplantation or chemotherapy in children with B-precursor acute lymphoblastic leukemia in a second remission: a collaborative study of the Children's Oncology Group and the Center for International Blood and Marrow Transplant Research. Blood 2006; 107: 4961-4967. (Pubitemid 43882651)
9. Schrauder A, Reiter A, Gadner H, Niethammer D, Klingebiel T, Kremens B et al. Superiority of allogeneic hematopoietic stem-cell transplantation compared with chemotherapy alone in high-risk childhood T-cell acute lymphoblastic leukemia: results from ALL-BFM 90 and 95. J Clin Oncol 2006; 24: 5742-5749. (Pubitemid 46631317)